Insulin and its analogs: Actions via insulin and IGF receptors

Acta Diabetologica

Volumn 47, Issue 4, 2010, Pages 271-278

  Vigneri, R ^a   Squatrito, S ^a   Sciacca, L ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

IGF I receptor; Insulin; Insulin analogs; Insulin receptor; Insulin receptor isoforms

Indexed keywords

HUMAN INSULIN; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; INSULIN RECEPTOR; INSULIN RECEPTOR A; INSULIN RECEPTOR B; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; SOMATOMEDIN RECEPTOR; UNCLASSIFIED DRUG;

BINDING AFFINITY; DIABETES CONTROL; DIABETES MELLITUS; DRUG ABSORPTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG METABOLISM; DRUG RECEPTOR BINDING; DRUG SAFETY; ENZYME ACTIVATION; HORMONE ACTION; HUMAN; INSULIN TREATMENT; LIGAND BINDING; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; RECOMBINANT DNA TECHNOLOGY; REVIEW; RISK BENEFIT ANALYSIS; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PROTEIN BINDING; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

EID: 78549247886     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-010-0215-3     Document Type: Review

References (35)

1. A Belfiore F Frasca G Pandini L Sciacca R Vigneri 2009 Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease Endocr Rev 30 586 623 1:CAS:528:DC%2BD1MXhsVyhsrbK 10.1210/er.2008-0047 19752219
2. F Frasca G Pandini P Scalia, et al. 1999 Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells Mol Cell Biol 19 3278 3288 1:CAS:528:DyaK1MXislSltLk%3D 10207053
3. C Blanquart J Achi T Issad 2008 Characterization of IRA/IRB hybrid insulin receptors using bioluminescence resonance energy transfer Biochem Pharmacol 76 873 883 1:CAS:528:DC%2BD1cXhtFaitr3M 10.1016/j.bcp.2008.07.027 18718450
4. G Pandini R Vigneri A Costantino, et al. 1999 Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling Clin Cancer Res 5 1935 1944 1:CAS:528:DyaK1MXltVCqtL8%3D 10430101
5. EM Bailyes BT Nave MA Soos SR Orr AC Hayward K Siddle 1997 Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting Biochem J 327 Pt 1 209 215 1:CAS:528:DyaK2sXmvVGktrw%3D 9355755
6. F Holleman JB Hoekstra 1997 Insulin lispro N Engl J Med 337 176 183 1:CAS:528:DyaK2sXlt1Smurs%3D 10.1056/NEJM199707173370307 9219705 (Pubitemid 27306290)
7. DN Brems LA Alter MJ Beckage, et al. 1992 Altering the association properties of insulin by amino acid replacement Protein Eng 5 527 533 1:CAS:528:DyaK38XmsVGksrc%3D 10.1093/protein/5.6.527 1438163
8. LJ Slieker K Sundell 1991 Modifications in the 28-29 position of the insulin B-chain alter binding to the IGF-I receptor with minimal effect on insulin receptor binding Diabetes 40 Suppl 1 168A
9. DC Howey RR Bowsher RL Brunelle JR Woodworth 1994 [Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin Diabetes 43 396 402 1:CAS:528:DyaK2cXhvVems7o%3D 10.2337/diabetes.43.3.396 8314011
10. KL Simpson CM Spencer 1999 Insulin aspart Drugs 57 759 765 1:CAS:528:DyaK1MXjs1altbc%3D 10.2165/00003495-199957050-00013 10353301 (discussion 766-757) (Pubitemid 29231892)
11. P Kurtzhals L Schaffer A Sorensen, et al. 2000 Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use Diabetes 49 999 1005 1:CAS:528:DC%2BD3cXjvFylu7w%3D 10.2337/diabetes.49.6.999 10866053
12. J Plank A Wutte G Brunner, et al. 2002 A direct comparison of insulin aspart and insulin lispro in patients with type 1 diabetes Diabetes Care 25 2053 2057 10.2337/diacare.25.11.2053 12401756 (Pubitemid 41071068)
13. RH Becker 2007 Insulin glulisine complementing basal insulins: a review of structure and activity Diabetes Technol Ther 9 109 121 1:CAS:528: DC%2BD2sXhvF2hsro%3D 10.1089/dia.2006.0035 17316105
14. RH Becker AD Frick 2008 Clinical pharmacokinetics and pharmacodynamics of insulin glulisine Clin Pharmacokinet 47 7 20 1:CAS:528:DC%2BD1cXhvF2qurs%3D 10.2165/00003088-200847010-00002 18076215
15. GB Bolli RD Di Marchi GD Park S Pramming VA Koivisto 1999 Insulin analogues and their potential in the management of diabetes mellitus Diabetologia 42 1151 1167 1:CAS:528:DyaK1MXmt1ymtr0%3D 10.1007/s001250051286 10525654 (Pubitemid 29459810)
16. DR Owens PA Coates SD Luzio JP Tinbergen R Kurzhals 2000 Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites Diabetes Care 23 813 819 1:CAS:528:DC%2BD3cXnvV2isLw%3D 10.2337/diacare.23.6.813 10841002
17. J Markussen S Havelund P Kurtzhals, et al. 1996 Soluble, fatty acid acylated insulins bind to albumin and show protracted action in pigs Diabetologia 39 281 288 1:CAS:528:DyaK28XitlaisLw%3D 10.1007/BF00418343 8721773
18. T Wada M Azegami M Sugiyama H Tsuneki T Sasaoka 2008 Characteristics of signalling properties mediated by long-acting insulin analogue glargine and detemir in target cells of insulin Diabetes Res Clin Pract 81 269 277 1:CAS:528:DC%2BD1cXhtVWitLbJ 10.1016/j.diabres.2008.05.007 18585815
19. CM Taniguchi B Emanuelli CR Kahn 2006 Critical nodes in signalling pathways: insights into insulin action Nat Rev Mol Cell Biol 7 85 96 1:CAS:528:DC%2BD28XhtlWnsLw%3D 10.1038/nrm1837 16493415 (Pubitemid 43278292)
20. A Morrione B Valentinis SQ Xu, et al. 1997 Insulin-like growth factor II stimulates cell proliferation through the insulin receptor Proc Natl Acad Sci USA 94 3777 3782 1:CAS:528:DyaK2sXis1anu7k%3D 10.1073/pnas.94.8.3777 9108054 (Pubitemid 27180449)
21. L Sciacca R Mineo G Pandini A Murabito R Vigneri A Belfiore 2002 In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A Oncogene 21 8240 8250 1:CAS:528:DC%2BD38XovVGmsL0%3D 10.1038/sj.onc.1206058 12447687 (Pubitemid 35477864)
22. G Pandini E Medico E Conte L Sciacca R Vigneri A Belfiore 2003 Differential gene expression induced by insulin and insulin-like growth factor-II through the insulin receptor isoform A J Biol Chem 278 42178 42189 1:CAS:528:DC%2BD3sXot1amtbw%3D 10.1074/jbc.M304980200 12881524 (Pubitemid 37310484)
23. L Sciacca MF Cassarino M Genua, et al. 2010 Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling Diabetologia 53 1743 1753 1:CAS:528:DC%2BC3cXotVKgsL4%3D 10.1007/s00125-010-1760-6 20424816
24. LH Dideriksen JLN Jorgensen K Drejer 1992 Carcinogenic effect on female rats after 12 months administration of the insulin analog B10 Asp Diabetes 41 143A
25. G Milazzo L Sciacca V Papa ID Goldfine R Vigneri 1997 ASPB10 insulin induction of increased mitogenic responses and phenotypic changes in human breast epithelial cells: evidence for enhanced interactions with the insulin-like growth factor-I receptor Mol Carcinog 18 19 25 1:CAS:528: DyaK2sXhtVWrs7k%3D 10.1002/(SICI)1098-2744(199701)18:1<19::AID-MC3>3.0. CO;2-M 9022809 (Pubitemid 27107371)
26. K Drejer 1992 The bioactivity of insulin analogues from in vitro receptor binding to in vivo glucose uptake Diabetes Metab Rev 8 259 285 1:CAS:528:DyaK3sXisVOks7o%3D 10.1002/dmr.5610080305 1338040
27. MR Sommerfeld G Muller G Tschank, et al. 2010 In vitro metabolic and mitogenic signaling of insulin glargine and its metabolites PLoS One 5 e9540 10.1371/journal.pone.0009540 20209060
28. CP Moxham V Duronio S Jacobs 1989 Insulin-like growth factor I receptor beta-subunit heterogeneity. Evidence for hybrid tetramers composed of insulin-like growth factor I and insulin receptor heterodimers J Biol Chem 264 13238 13244 1:CAS:528:DyaL1MXkvFSrtb4%3D 2546949
29. G Pandini F Frasca R Mineo L Sciacca R Vigneri A Belfiore 2002 Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved J Biol Chem 277 39684 39695 1:CAS:528:DC%2BD38XnvVeiu74%3D 10.1074/jbc.M202766200 12138094 (Pubitemid 35190951)
30. A Agin N Jeandidier F Gasser D Grucker R Sapin 2007 Glargine blood biotransformation: in vitro appraisal with human insulin immunoassay Diabetes Metab 33 205 212 1:CAS:528:DC%2BD2sXptFGnurg%3D 10.1016/j.diabet.2006.12.002 17360218 (Pubitemid 46863409)
31. S Havelund A Plum U Ribel, et al. 2004 The mechanism of protraction of insulin detemir, a long-acting, acylated analog of human insulin Pharm Res 21 1498 1504 1:CAS:528:DC%2BD2cXmtlGntbg%3D 10.1023/B:PHAM.0000036926.54824.37 15359587 (Pubitemid 39149667)
32. AM Hennige V Strack E Metzinger G Seipke HU Haring M Kellerer 2005 Effects of new insulin analogues HMR1964 (insulin glulisine) and HMR1423 on insulin receptors Diabetologia 48 1891 1897 1:CAS:528:DC%2BD2MXhtVSqtL%2FI 10.1007/s00125-005-1870-8 16052329 (Pubitemid 41317845)
33. L Berti M Kellerer B Bossenmaier E Seffer G Seipke HU Haring 1998 The long acting human insulin analog HOE 901: characteristics of insulin signalling in comparison to Asp(B10) and regular insulin Horm Metab Res 30 123 129 1:CAS:528:DyaK1cXitVClt7w%3D 10.1055/s-2007-978849 9566852
34. M Bahr T Kolter G Seipke J Eckel 1997 Growth promoting and metabolic activity of the human insulin analogue [GlyA21, ArgB31, ArgB32]insulin (HOE 901) in muscle cells Eur J Pharmacol 320 259 265 1:STN:280:DyaK2s3htlSrsA%3D%3D 10.1016/S0014-2999(96)00903-X 9059862 (Pubitemid 27076754)
35. LJ Slieker GS Brooke RD DiMarchi, et al. 1997 Modifications in the B10 and B26-30 regions of the B chain of human insulin alter affinity for the human IGF-I receptor more than for the insulin receptor Diabetologia 40 Suppl 2 S54 S61 1:CAS:528:DyaK2sXksFems7k%3D 10.1007/s001250051402 9248702 (Pubitemid 27306923)